AstraZeneca
This role involves leading the design and implementation of robust bioanalytical strategies, including pharmacokinetics, immunogenicity, and biomarkers, to support the AstraZeneca pipeline. The position requires close collaboration with internal and external laboratory teams, CROs, and cross-functional stakeholders to ensure the development and validation of assays aligned with their intended context of use. As a subject matter expert, the individual will provide scientific oversight and delivery for the Oncology portfolio, manage stakeholder expectations, and contribute to strategic initiatives within the IBA Global Oncology Strategy team.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
38% above the average for this role
Clinical Bioanalysis Subject Matter Expert
Scholar Rock
Principal Scientist - Immunogenicity Research Laboratory
Syngene International Limited
Principal Scientist - Immunogenicity Bioanalytical Sciences
Amgen
Lead Scientist-BioAnalytical
Massachusetts General Hospital
Senior Scientist, Bioanalytical Sciences (Innate Immunity, Ligand Binding Assays & Flow Cytometry)
Flagship Pioneering, Inc.
Senior Director, Bioanalysis
Beeline Medicines